Form 4 for AGL agilon health, inc.

Accepted 2023-04-18 00:00:00 ET · period of report 2023-04-14 · accession 0001209191-23-024665 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2023-04-18	2023-04-14	AGL	Bensley Timothy	CFO	A - Grant	$0.00	+11.0K	38.0K	+41%	$0
D	2023-04-18	2023-04-14	AGL	Bensley Timothy	CFO	F - Tax	$28.46	-2,871	35.2K	-8%	-$81.7K
D	2023-04-18	2023-04-14	AGL	Bensley Timothy	CFO	A - Grant	$0.00	+19.0K	19.0K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-04-14	A	A	10,981	$0.00	38,042	D	—	—	(F1) Restricted stock units that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. (F2) Includes restricted stock units. (F3) The total was decreased by 1,430 shares as reported in the Form 4 Amendment filed on September 29, 2022.
2	Common	Common Stock	2023-04-14	F	D	2,871	$28.46	35,171	D	—	—	(F4) Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. (F2) Includes restricted stock units. (F3) The total was decreased by 1,430 shares as reported in the Form 4 Amendment filed on September 29, 2022.
3	Derivative	Options (Rights to Buy)	2023-04-14	A	A	18,986	$0.00	18,986	D	$28.46 · — to 2033-04-14	18,986 Common Stock	(F5) Options that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment.